Amiloride- and atenolol- and hydrochlorothiazide-containing product in oral dose form
RxNorm 1151590
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1151590 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Amiloride- and atenolol- and hydrochlorothiazide-containing product in oral dose form.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDG
Semantic Clinical Dose Form Group (SCDG):
Amiloride / atenolol / hydrochlorothiazide Oral Product
(Atom ID: 12293495)
TMSY
Tall Man Lettering Synonym (TMSY):
AMILoride / atenolol / hydroCHLOROthiazide Oral Product
(Atom ID: 12428215)
PT
Designated preferred name (PT):
Amiloride- and atenolol- and hydrochlorothiazide-containing product in oral dose form
(Atom ID: 10796414)
FN